How To Put A Price Tag On Emerging Therapies
Source: Life Science Leader
By Herman Sanchez & Andrew Combs
There’s no doubt that partnerships and M&As are key growth drivers in the biopharma industry. But for collaborative relationships to occur, understanding the value of a company’s underlying assets is critical.
Forecast and valuation engagements in the life sciences industry have grown following recent venture investment trends. According to Evaluate, between 2012 and 2017, both total investments and average investments per financing event increased by about 20 percent each year.
access the Magazine Article!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Life Science Leader? Subscribe today.
Subscribe to Life Science Leader
X
Subscribe to Life Science Leader
This website uses cookies to ensure you get the best experience on our website. Learn more